Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia - PubMed
Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia
Todd P Margolis et al. J Virol. 2007 Oct.
Abstract
Careful studies of mouse trigeminal ganglia (TG) latently infected with herpes simplex virus type 1 (HSV-1) indicate the presence of productive cycle viral gene products and persistent immune response, suggesting ongoing spontaneous viral reactivation in these tissues. In the present study we set out to determine whether infectious virus is present in murine TG latently infected with HSV-1 (KOS). At 37 days after ocular inoculation we found a small amount of infectious virus in ca. 6% of latently infected murine TG. Furthermore, the amount of infectious virus that we detected (PFU per viral antigen-positive neuron) was similar to that detected in acutely infected ganglia. We conclude that spontaneous reactivation of infectious HSV-1 occurs in the mouse TG and is likely the principle cause of viral protein expression in these tissues. We next examined the role of latency-associated transcript (LAT) in spontaneous ganglionic reactivation by examining ganglia latently infected with KOS dlLAT1.8, a LAT deletion virus. Through the use of immunocytochemistry we found that KOS dlLAT1.8 had a rate of spontaneous ganglionic reactivation very similar to that of HSV-1 (KOS). Studying spontaneous ganglionic reactivation of HSV in the mouse TG allows a direct study of viral reactivation from latently infected neurons without the potential confounders and complicating downstream events that accompany the study of viral reactivation by explantation or peripheral viral shedding. Since most cases of human viral shedding and reactivation are not associated with a known trigger, spontaneous ganglionic reactivation of HSV-1 may be a better model of human disease than existing models.
Figures
![FIG. 1.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce67/2045564/213566b30485/zjv0200797680001.gif)
Immunohistochemical staining of TG 37 days postinoculation. Four examples of HSV-1 antigen staining in “latently' infected tissue. (A) HSV-1 antigen-positive neuron. (B) HSV-1 antigen and apoptotic cellular material surrounded by inflammatory cells. (C and D) HSV-1 antigen and cellular debris in foci of inflammation. These images suggest that not only are viral proteins expressed in rare neurons of “latently” infected ganglia but also that this process is associated with cellular destruction and subsequent spread to adjacent cells (glia and white blood cells). Bar, 50 μm.
![FIG. 2.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce67/2045564/a52e7c68f608/zjv0200797680002.gif)
Crystal violet staining of viral plaques from TG homogenates 4 and 37 days after ocular inoculation with HSV-1. The inset is a magnified view of the single plaque from the “latently” infected mouse at 37 days p.i.
![FIG. 3.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce67/2045564/737419651869/zjv0200797680003.gif)
Immunostaining of viral plaques from TG homogenates 4 and 37 days after ocular inoculation with HSV-1. The inset is a magnified view of the single HSV-1 antigen-positive plaque from the “latently” infected mouse at 37 days p.i.
![FIG. 4.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce67/2045564/e1958531f0a4/zjv0200797680004.gif)
Confocal images of a spontaneously reactivating neuron in a latently infected mouse trigeminal ganglion. (A) Nuclear staining with TO-PRO-3-iodide. (B) Neuronal specific staining with anti-NeuN antisera. (C) Staining of productively infected neuron with HSV-1 specific antisera. (D) Merged image. Bar, 100 μm.
![FIG. 5.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce67/2045564/108930f8bef3/zjv0200797680005.gif)
Immunohistochemical staining of TG 37 days after ocular inoculation with either HSV-1 KOS (left) or HSV-1 KOS dl1.8 (right). As assayed in this manner, the rate of spontaneous reactivation of these two viruses was similar. Bar, 100 μm.
Similar articles
-
ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.
Halford WP, Schaffer PA. Halford WP, et al. J Virol. 2001 Apr;75(7):3240-9. doi: 10.1128/JVI.75.7.3240-3249.2001. J Virol. 2001. PMID: 11238850 Free PMC article.
-
Li L, Li Z, Wang E, Yang R, Xiao Y, Han H, Lang F, Li X, Xia Y, Gao F, Li Q, Fraser NW, Zhou J. Li L, et al. J Virol. 2015 Oct 28;90(2):790-804. doi: 10.1128/JVI.02258-15. Print 2016 Jan 15. J Virol. 2015. PMID: 26512084 Free PMC article.
-
Doll JR, Thompson RL, Sawtell NM. Doll JR, et al. J Virol. 2019 Apr 3;93(8):e02209-18. doi: 10.1128/JVI.02209-18. Print 2019 Apr 15. J Virol. 2019. PMID: 30728262 Free PMC article.
-
A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.
Kennedy PG, Rovnak J, Badani H, Cohrs RJ. Kennedy PG, et al. J Gen Virol. 2015 Jul;96(Pt 7):1581-602. doi: 10.1099/vir.0.000128. Epub 2015 Mar 20. J Gen Virol. 2015. PMID: 25794504 Free PMC article. Review.
-
Herpes simplex virus type 1 and bovine herpesvirus 1 latency.
Jones C. Jones C. Clin Microbiol Rev. 2003 Jan;16(1):79-95. doi: 10.1128/CMR.16.1.79-95.2003. Clin Microbiol Rev. 2003. PMID: 12525426 Free PMC article. Review.
Cited by
-
A cultured affair: HSV latency and reactivation in neurons.
Wilson AC, Mohr I. Wilson AC, et al. Trends Microbiol. 2012 Dec;20(12):604-11. doi: 10.1016/j.tim.2012.08.005. Epub 2012 Sep 7. Trends Microbiol. 2012. PMID: 22963857 Free PMC article. Review.
-
Clinical and molecular aspects of varicella zoster virus infection.
Gilden D, Nagel MA, Mahalingam R, Mueller NH, Brazeau EA, Pugazhenthi S, Cohrs RJ. Gilden D, et al. Future Neurol. 2009 Jan 1;4(1):103-117. doi: 10.2217/14796708.4.1.103. Future Neurol. 2009. PMID: 19946620 Free PMC article.
-
Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.
Edwards RG, Longnecker R. Edwards RG, et al. J Virol. 2017 Jun 9;91(13):e00115-17. doi: 10.1128/JVI.00115-17. Print 2017 Jul 1. J Virol. 2017. PMID: 28404853 Free PMC article. Review.
-
Lytic promoter activity during herpes simplex virus latency is dependent on genome location.
Singh N, Zachariah S, Phillips AT, Tscharke D. Singh N, et al. J Virol. 2024 Nov 19;98(11):e0125824. doi: 10.1128/jvi.01258-24. Epub 2024 Oct 21. J Virol. 2024. PMID: 39431845 Free PMC article.
-
Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases.
Webre JM, Hill JM, Nolan NM, Clement C, McFerrin HE, Bhattacharjee PS, Hsia V, Neumann DM, Foster TP, Lukiw WJ, Thompson HW. Webre JM, et al. J Biomed Biotechnol. 2012;2012:612316. doi: 10.1155/2012/612316. Epub 2012 Oct 2. J Biomed Biotechnol. 2012. PMID: 23091352 Free PMC article. Review.
References
-
- Atanasiu, D., J. R. Kent, J. J. Gartner, and N. W. Fraser. 2006. The stable 2-kb LAT intron of herpes simplex stimulates the expression of heat shock proteins and protects cells from stress. Virol. 350:26-33. - PubMed
-
- Bloom, D. C. 2006. HSV-1 Latency and the roles of the LATs, p. 325-341. In R. M. Sandri-Goldin (ed.), Alpha herpesviruses: molecular and cellular biology. Ciaster Academic Press, Norfolk, United Kingdom.
-
- Chen, S. H., D. A. Garber, P. A. Schaffer, D. M. Knipe, and D. M. Coen. 2000. Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation. Virol. 278:207-216. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous